Should the number of operations that a surgeon performs be their main criteria for judgment? Certainly not, but that number offers patients some crucial, basic information about their surgeon.
Is the beloved program on its last legs?
Price-cutting initiatives have been pulled off the White House docket, and drug makers are working hard to maintain their rising profits.
One of the hidden costs of long-term care is caregiving, and it’s increasingly vexing the individuals who take responsibility for their elderly relatives and others with continuing illnesses.
Buyer Beware: The Centers for Medicare and Medicaid Services’ warning and watch lists for nursing homes is not widely publicized, and the rating system is not easy to understand.
Discharged patients are often faced with limited choices and information about what comes next.
Hospitals tout their research budgets as a reason to choose them over the competition. Patients would make much better decisions by knowing their infection or readmission rates.
They’re marketed as cheap, quick coverage, but this type of insurance won’t necessarily be there when you need it.
If you are wondering why a doctor won’t consider prescribing a cheaper prescription drug, consider exploring Medicare’s database of pharma payments to physicians.
Some seniors enrolled in Medicare have a three-month period where they can consider switching their plans, so Trudy Lieberman considers whether it’s worth making the change.
Some states are once again offering insurance across trade organizations or business groups, but will the revamped program have the same old flaws?
A two month coma, a misdiagnosis and a $3 million bill.
Without the protections in the Affordable Care Act, many would find themselves back in the “bad old days.”
A cheaper premium or no premium sounds good when you’re well, but what happens when you’re sick?